|
|
| | Avizakimab Basic information |
| Product Name: | Avizakimab | | Synonyms: | Avizakimab;Research Grade Avizakimab;Avizakimab (anti-IL-21) | | CAS: | 2229685-51-0 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Avizakimab Structure]() |
| | Avizakimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Avizakimab Usage And Synthesis |
| Uses | Avizakimab (BOS161721) is a humanized IgG1 monoclonal antibody that targets interleukin-21[1]. | | References | [1] Hussaini A, et al. A Double-Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects. Clin Transl Sci. 2020 Mar;13(2):337-344. DOI:10.1111/cts.12715 |
| | Avizakimab Preparation Products And Raw materials |
|